The National Agency of Ukraine for the Identification, Tracing, and Management of Assets Derived from Corruption and Other Crimes (Asset Tracing and Management Agency, ARMA) continues to manage the stake in the distributor Venta Ltd. that belonged to the Russian company Katren.
“In accordance with the rulings of the Pechersky District Court of Kyiv, a 24% stake in the authorized capital of Venta Ltd., owned by Katren JSC (Russia), has been transferred to ARMA’s management. “The aforementioned asset is currently under ARMA’s management,” ARMA told Interfax-Ukraine.
ARMA notes that following a competitive selection process, an asset management agreement was concluded between ARMA and I.K.VEL LLC. At the same time, ARMA subsequently decided to unilaterally terminate the agreement due to information available at the time regarding a possible connection between “I.K.VEL” and individuals associated with the owners of the seized asset (JSC “KATREN” and the ultimate beneficiary of “Venta Ltd,” Oleksandr Voloshin).
However, in a decision by the Commercial Court of Kyiv dated April 22, 2026, in response to a lawsuit filed by “I.K.VEL,” the court concluded that there was insufficient evidence of such a connection.
The court also found that there were no legal grounds for rejecting the results of the tender for the management of the Russian share of “Venta Ltd.” and for failing to transfer the asset to the manager—the winning bidder.
As reported, in 2022, Venta. Ltd. (Dnipro), which was among the top three pharmaceutical distributors in Ukraine, transferred the corporate rights belonging to the Russian JSC “Katren” to the management of ARMA. According to the pharmaceutical distributor, the transfer of corporate rights took place on August 1 at the initiative of the company’s management and in cooperation with the Office of the Prosecutor General of Ukraine. The transfer of the Russian stake occurred pursuant to a court decision as part of criminal proceedings.
According to Venta.Ltd’s estimates, the company’s share of Ukraine’s pharmaceutical market stood at 10–11% as of early 2022; by the end of 2024, Venta.Ltd had reduced its net profit by 2.1% to UAH 187.134 million.
ARMA selected I.K.VEL LLC to manage the seized Russian stake in Venta.Ltd (24% of the company). The auction to select a manager for this stake was participated in by the Citizens’ Association “VIZAVI Rehabilitation Center,” which offered 0.01 hryvnia for the lot, I.K.VEL LLC (58,550 hryvnia), and Comfortna Apteka LLC (120,000 hryvnia).
I.K.VEL LLC is engaged in the retail sale of pharmaceutical products in specialty stores. According to the YuoControl system, the company’s current beneficiary is Mykyta Kholodov.
